We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · September 11, 2021

Dual Therapy in Patients With Advanced Renal Cell Carcinoma of Favorable Risk

Urology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Urology
A Systematic Review and Meta-Analysis of Dual Therapy in Patients With Advanced Renal Cell Carcinoma of Favourable Risk
Urology 2021 Aug 27;[EPub Ahead of Print], A Kartolo, RG Holstead, I Duran, AG Robinson, FE Vera-Badillo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Renal Cell Carcinoma Center of Excellence

Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.


Further Reading